NPS Gattex Launch Preparations Focus On Clinical Care Coordinators
This article was originally published in The Pink Sheet Daily
Executive Summary
The rare-disease focused company is putting commercial plans in place for its first drug, Gattex, which could launch early next year, and is preparing to file a second NDA in mid-2013, later than expected due to requirements from FDA.